share_log

6-K: Blenrep Combination Reduced the Risk of Disease Progression or Death by Nearly 50% Versus Standard of Care Combination in Relapsed/Refractory Multiple Myeloma

6-K: Blenrep Combination Reduced the Risk of Disease Progression or Death by Nearly 50% Versus Standard of Care Combination in Relapsed/Refractory Multiple Myeloma

6-K:与标准护理组合相比,Blenrep组合可将复发/难治性多发性骨髓瘤的疾病进展或死亡风险降低近50%
美股sec公告 ·  06/03 06:15
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息